Gastrointestinal OTC Drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Gastrointestinal OTC Drugs Market size is expected to grow at an annual average of 6% during 2021-2027. Gastrointestinal diseases include complications related to the stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver, and pancreas. Over-the-counter (OTC) medications are over-the-counter medications used to control vomiting, constipation, diarrhea, and flatulence.

The following segmentation are covered in this report:

By Product

• Laxatives
• Gastrointestinal Cancer Treatments
• Gastric Acid Reducers
• Anti-Diarrheal
• Proton Pump Inhibitors
• H2 Inhibitors
• Gastric Acid Neutralizers
• Bowel Anti-Inflammatory
• Anti-Emetics

By End User

• Clinics
• Pharmacies
• Hospitals
• Others

By Indication

• Gastroesophageal Reflux Disease (GERD) or Heartburn
• Constipation
• Diarrhea
• Motion Sickness
• Flatulence

Company Profile

• Bayer
• GlaxoSmithKline
• Johnson & Johnson
• Perrigo
• Pfizer
• Procter & Gamble

Scope of the report

The research study analyses the Gastrointestinal OTC Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Gastrointestinal OTC Drugs Market Report

• What was the Gastrointestinal OTC Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Gastrointestinal OTC Drugs Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.